CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
Clinical and Experimental Metastasis, 05/25/2012Meng E et al.
The CD44+/CD24- phenotype in ovarian cancer cells demonstrate cancer stem cell–like properties of enhanced differentiation, invasion, and resistance to chemotherapy. This CD44+/CD24- phenotype correlates to clinical endpoints with increased risk of recurrence and shorter progression–free survival in patients with ovarian cancer.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.